Skip to main content
SpringerLink
Log in

Expression of membrane type 1-matrix metalloproteinase in laryngeal carcinoma

  • Article
  • Published:
Pathology & Oncology Research

Abstract

Membrane type 1-matrix metalloproteinase (MT1-MMP) is a member of the recently identified unique membrane-type subgroup in the matrix metalloproteinase (MMP) family. MT1-MMP has proteolytic activity against components of the extracellular matrix and activates progelatinase A (MMP-2) at the cell surface. In this study, we analyzed the expression of MT1-MMP mRNA in 45 cases of laryngeal carcinoma by RT-PCR and investigated the relationship between MT1-MMP expression and survival in 18 cases. The result showed that the expression of MT1-MMP mRNA was higher in tumor tissue than in corresponding normal tissue. The tumoral expression in clinical stage III was higher than in stage II. The tumoral expression level of MT1-MMP mRNA in patients with lymph node metastasis was signigicantly higher than those with negative lymph nodes. The patients with high expression level showed significantly poorer 5 year survival than those with low expression level. Collectively, our findings suggest that the high level of MT1-MMP expression is closely related to the invasion and metastasis of laryngeal carcinoma, and indicates poorer prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121–125, 1990.

    Article  PubMed  CAS  Google Scholar 

  2. Woessner JFJ: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145–2154, 1991.

    PubMed  CAS  Google Scholar 

  3. Cao J, Sato H, Takino T, et al: The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required of pro-gelatinase A activation. J Biol Chem 270:801–805, 1995.

    Article  PubMed  CAS  Google Scholar 

  4. Emonard HP, Remacle AG, Noel AC, et al: Tumor cell surface-associated binding site for the Mr 72.000 type IV collagenase. Cancer Res 52:5845–5848, 1992.

    PubMed  CAS  Google Scholar 

  5. Pei D, Weiss S: Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process proglatianse A and express intrinsic matrix-degrading activity. J Biol Chem 271:9135–9140, 1996.

    Article  PubMed  CAS  Google Scholar 

  6. Kinoshita T, Sato H, Takino T, et al: Processing of a precursor of 72kDa type IV collagenase/gelatinase A by a recombinant membrane type 1 matrix metalloproteinase. Cancer Res 56:2535–2538, 1996.

    PubMed  CAS  Google Scholar 

  7. Sato H, Takino T, Okada Y, et al: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370:61–65, 1994.

    Article  PubMed  CAS  Google Scholar 

  8. Bando E, Yonemura Y, Endou Y, et al: Immunohistochemical study of MTMMP tissue status in gastric carcinoma and correlation with survival analyzed by univariate and multivariate analysis. Oncol Rep 5: 1483–1488, 1998.

    PubMed  CAS  Google Scholar 

  9. Mori M, Mimori K, Shiraishi T, et al: Analysis of MT1-MMP and MMP2 expression in human gastric cancers. Int J Cancer 74:316–321, 1997.

    Article  PubMed  CAS  Google Scholar 

  10. YamamotoM, Mahanam S, Sawaya R, et al: Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 56:384–392, 1996.

    PubMed  CAS  Google Scholar 

  11. Gilles C, Polette M, Piette J, et al: High level of MT1-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer 65:209–213, 1996.

    Article  PubMed  CAS  Google Scholar 

  12. Tokuraku M, Sato H, Shinagawa A, et al: Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinoma correlation with the expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) and with lymph node metastasis. Int J Cancer 64: 355–359, 1995.

    Article  PubMed  CAS  Google Scholar 

  13. Yoshizaki T, Sato H, Maruyama Y, et al: Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer 79:139–144, 1977.

    Article  Google Scholar 

  14. Répássy G, Forster-Horváth Cs, Juhász A, et al. Expression of invasion markers CD44v6/v3, nm23 and MMP2 in laryngeal and hypopharyngeal carcinoma. Pathol Oncol Res 4:14–22, 1998.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of ENT & HN, First Clinical Hospital, Norman Bethune University of Medical Sciences, 130021, Chang Chun, Ji Lin, PR China

    Bo Du, Ping Wang, Xiaofeng Guo & Baodong Du

Authors
  1. Bo Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ping Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaofeng Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Baodong Du
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bo Du.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bo, D., Ping, W., Xiaofeng, G. et al. Expression of membrane type 1-matrix metalloproteinase in laryngeal carcinoma. Pathol. Oncol. Res. 5, 214–217 (1999). https://doi.org/10.1053/paor.1999.0217

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1053/paor.1999.0217

Keywords

Search

Navigation